![]()
|
|
||||||||
(Received for publication, October 24, 1995; and in revised form, January 30, 1996) Engagement of the CD95 (APO-1/Fas) receptor induces apoptosis in
a variety of cell types. However, the nature of the cytotoxic signal
and the intermediate messenger molecules remain to be elucidated. In an
effort to understand CD95-mediated signaling, we assessed possible
changes in the DNA binding activity of NF-
Volume 271,
Number 15,
Issue of April 12, 1996 pp. 8991-8995
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
B Independently of Its Cytotoxic
Function
B as a result of CD95
engagement in various tumor cells. By performing electrophoresis
mobility shift assays, we show that CD95 can stimulate the DNA binding
activity of NF-
B in a variety of cells, irrespective of their
sensitivity or resistance to CD95-mediated cytotoxicity. Moreover,
deletion of 37 carboxyl-terminal residues from the cytoplasmic domain
of CD95, which abrogates CD95-mediated apoptosis, only marginally
affects NF-
B activation. Taken together, these observations
indicate that CD95 has a function that involves activation of NF-
B
and that appears to be unrelated to its role as an inducer of apoptotic
cell death.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Li, X. Cai, X. Fan, B. Moquin, C. Stoicov, and J. Houghton Fas Ag-FasL coupling leads to ERK1/2-mediated proliferation of gastric mucosal cells Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G263 - G275. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Altemeier, X. Zhu, W. R. Berrington, J. M. Harlan, and W. C. Liles Fas (CD95) induces macrophage proinflammatory chemokine production via a MyD88-dependent, caspase-independent pathway J. Leukoc. Biol., September 1, 2007; 82(3): 721 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Matute-Bello, M. M. Wurfel, J. S. Lee, D. R. Park, C. W. Frevert, D. K. Madtes, S. D. Shapiro, and T. R. Martin Essential Role of MMP-12 in Fas-Induced Lung Fibrosis Am. J. Respir. Cell Mol. Biol., August 1, 2007; 37(2): 210 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Beneteau, S. Daburon, J.-F. Moreau, J.-L. Taupin, and P. Legembre Dominant-Negative Fas Mutation Is Reversed by Down-expression of c-FLIP Cancer Res., January 1, 2007; 67(1): 108 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Bharhani, R. Borojevic, S. Basak, E. Ho, P. Zhou, and K. Croitoru IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression. Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G820 - G829. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kang, S.-K. Kang, Y.-C. Lee, H.-J. Choi, Y.-S. Lee, S.-Y. Cho, Y.-S. Kim, J.-H. Ko, and C.-H. Kim Transcriptional regulation of the human GD3 synthase gene expression in Fas-induced Jurkat T cells: a critical role of transcription factor NF-{kappa}B in regulated expression Glycobiology, May 1, 2006; 16(5): 375 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Braun, G. Carvalho, A. Coquelle, M.-C. Vozenin, P. Lepelley, F. Hirsch, J.-J. Kiladjian, V. Ribrag, P. Fenaux, and G. Kroemer NF-{kappa}B constitutes a potential therapeutic target in high-risk myelodysplastic syndrome Blood, February 1, 2006; 107(3): 1156 - 1165. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Matute-Bello, J. S. Lee, W. C. Liles, C. W. Frevert, S. Mongovin, V. Wong, K. Ballman, S. Sutlief, and T. R. Martin Fas-Mediated Acute Lung Injury Requires Fas Expression on Nonmyeloid Cells of the Lung J. Immunol., September 15, 2005; 175(6): 4069 - 4075. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Soderstrom, S. D. Nyberg, and J. E. Eriksson CD95 capping is ROCK-dependent and dispensable for apoptosis J. Cell Sci., May 15, 2005; 118(10): 2211 - 2223. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Golks, D. Brenner, C. Fritsch, P. H. Krammer, and I. N. Lavrik c-FLIPR, a New Regulator of Death Receptor-induced Apoptosis J. Biol. Chem., April 15, 2005; 280(15): 14507 - 14513. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Imamura, K. Konaka, N. Matsumoto, M. Hasegawa, M. Fukui, N. Mukaida, T. Kinoshita, and T. Suda Fas Ligand Induces Cell-autonomous NF-{kappa}B Activation and Interleukin-8 Production by a Mechanism Distinct from That of Tumor Necrosis Factor-{alpha} J. Biol. Chem., November 5, 2004; 279(45): 46415 - 46423. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakamura, G. Matute-Bello, W. C. Liles, S. Hayashi, O. Kajikawa, S.-M. Lin, C. W. Frevert, and T. R. Martin Differential Response of Human Lung Epithelial Cells to Fas-Induced Apoptosis Am. J. Pathol., June 1, 2004; 164(6): 1949 - 1958. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mathas, A. Lietz, I. Anagnostopoulos, F. Hummel, B. Wiesner, M. Janz, F. Jundt, B. Hirsch, K. Johrens-Leder, H.-P. Vornlocher, et al. c-FLIP Mediates Resistance of Hodgkin/Reed-Sternberg Cells to Death Receptor-induced Apoptosis J. Exp. Med., April 19, 2004; 199(8): 1041 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Guo, M. Zhang, H. An, W. Chen, S. Liu, J. Guo, Y. Yu, and X. Cao Fas ligation induces IL-1{beta}-dependent maturation and IL-1{beta}-independent survival of dendritic cells: different roles of ERK and NF-{kappa}B signaling pathways Blood, December 15, 2003; 102(13): 4441 - 4447. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Park, A. R. Thomsen, C. W. Frevert, U. Pham, S. J. Skerrett, P. A. Kiener, and W. C. Liles Fas (CD95) Induces Proinflammatory Cytokine Responses by Human Monocytes and Monocyte-Derived Macrophages J. Immunol., June 15, 2003; 170(12): 6209 - 6216. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Xiao, S. Jodo, S.-s. J. Sung, A. Marshak-Rothstein, and S.-T. Ju A Novel Signaling Mechanism for Soluble CD95 Ligand. SYNERGY WITH ANTI-CD95 MONOCLONAL ANTIBODIES FOR APOPTOSIS AND NF-kappa B NUCLEAR TRANSLOCATION J. Biol. Chem., December 20, 2002; 277(52): 50907 - 50913. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Qin, B. Camoretti-Mercado, L. Blokh, C. G. Long, F. D. Ko, and K. J. Hamann Fas Resistance of Leukemic Eosinophils Is Due to Activation of NF-{kappa}B by Fas Ligation J. Immunol., October 1, 2002; 169(7): 3536 - 3544. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lu, L. Wang, D. Medan, D. Toledo, C. Huang, F. Chen, X. Shi, and Y. Rojanasakul Regulation of Fas (CD95)-induced apoptosis by nuclear factor-kappa B and tumor necrosis factor-alpha in macrophages Am J Physiol Cell Physiol, September 1, 2002; 283(3): C831 - C838. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Cook, T. A. Walker, G. S. Worthen, and J. R. Radke Role of the E1A Rb-binding domain in repression of the NF-kappa B-dependent defense against tumor necrosis factor-alpha PNAS, July 23, 2002; 99(15): 9966 - 9971. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Russo, B. L. Bennett, A. M. Manning, D. A. Brenner, and C. Jobin Differential requirement for NF-kappa B-inducing kinase in the induction of NF-kappa B by IL-1beta , TNF-alpha , and Fas Am J Physiol Cell Physiol, July 1, 2002; 283(1): C347 - C357. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Scheller, S. Sopper, P. Chen, E. Flory, E. Koutsilieri, T. Racek, S. Ludwig, V. ter Meulen, and C. Jassoy Caspase Inhibition Activates HIV in Latently Infected Cells. ROLE OF TUMOR NECROSIS FACTOR RECEPTOR 1 AND CD95 J. Biol. Chem., May 3, 2002; 277(18): 15459 - 15464. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. GILL, R. MESTRIL, and A. SAMALI Losing heart: the role of apoptosis in heart disease--a novel therapeutic target? FASEB J, February 1, 2002; 16(2): 135 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Ahn, S.-M. Park, H.-S. Cho, M.-S. Lee, J.-B. Yoon, J. Vilcek, and T. H. Lee Non-apoptotic Signaling Pathways Activated by Soluble Fas Ligand in Serum-starved Human Fibroblasts. MITOGEN-ACTIVATED PROTEIN KINASES AND NF-kappa B-DEPENDENT GENE EXPRESSION J. Biol. Chem., December 7, 2001; 276(50): 47100 - 47106. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Matute-Bello, W. C. Liles, C. W. Frevert, M. Nakamura, K. Ballman, C. Vathanaprida, P. A. Kiener, and T. R. Martin Recombinant human Fas ligand induces alveolar epithelial cell apoptosis and lung injury in rabbits Am J Physiol Lung Cell Mol Physiol, August 1, 2001; 281(2): L328 - L335. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Manos and D. A. Jones Assessment of Tumor Necrosis Factor Receptor and Fas Signaling Pathways by Transcriptional Profiling Cancer Res., January 1, 2001; 61(2): 433 - 438. [Abstract] [Full Text] |
||||
![]() |
G. Matute-Bello, R. K. Winn, M. Jonas, E. Y. Chi, T. R. Martin, and W. C. Liles Fas (CD95) Induces Alveolar Epithelial Cell Apoptosis in Vivo : Implications for Acute Pulmonary Inflammation Am. J. Pathol., January 1, 2001; 158(1): 153 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gulbins, A. Jekle, K. Ferlinz, H. Grassme, and F. Lang Physiology of apoptosis Am J Physiol Renal Physiol, October 1, 2000; 279(4): F605 - F615. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. S. Jean, C. Debbasch, M. Rahmani, F. Brignole, G. Feldmann, J.-M. Warnet, and C. Baudouin Fas- and Interferon {gamma}-Induced Apoptosis in Chang Conjunctival Cells: Further Investigations Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2531 - 2543. [Abstract] [Full Text] |
||||
![]() |
G. H. Gibbons and M. J. Pollman Death Receptors, Intimal Disease, and Gene Therapy : Are Therapies That Modify Cell Fate Moving too Fas? Circ. Res., May 26, 2000; 86(10): 1009 - 1012. [Full Text] [PDF] |
||||
![]() |
E. Hatano, C. A. Bradham, A. Stark, Y. Iimuro, J. J. Lemasters, and D. A. Brenner The Mitochondrial Permeability Transition Augments Fas-induced Apoptosis in Mouse Hepatocytes J. Biol. Chem., April 14, 2000; 275(16): 11814 - 11823. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-H. Hu, H. Johnson, and H.-B. Shu Activation of NF-kappa B by FADD, Casper, and Caspase-8 J. Biol. Chem., April 6, 2000; 275(15): 10838 - 10844. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Harwood, S. Kasibhatla, I. Petak, R. Vernes, D. R. Green, and J. A. Houghton Regulation of FasL by NF-kappa B and AP-1 in Fas-dependent Thymineless Death of Human Colon Carcinoma Cells J. Biol. Chem., March 31, 2000; 275(14): 10023 - 10029. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Wollert, J. Heineke, J. Westermann, M. Ludde, B. Fiedler, W. Zierhut, D. Laurent, M. K. A. Bauer, K. Schulze-Osthoff, and H. Drexler The Cardiac Fas (APO-1/CD95) Receptor/Fas Ligand System : Relation to Diastolic Wall Stress in Volume-Overload Hypertrophy In Vivo and Activation of the Transcription Factor AP-1 in Cardiac Myocytes Circulation, March 14, 2000; 101(10): 1172 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Schneider, G. Vassalli, S. Wen, R. M. Driscoll, A. B. Sassani, M. B. DeYoung, R. Linnemann, R. Virmani, and D. A. Dichek Expression of Fas Ligand in Arteries of Hypercholesterolemic Rabbits Accelerates Atherosclerotic Lesion Formation Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 298 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. CARDIER, T. SCHULTE, H. KAMMER, J. KWAK, and M. CARDIER Fas (CD95, APO-1) antigen expression and function in murine liver endothelial cells: implications for the regulation of apoptosis in liver endothelial cells FASEB J, November 1, 1999; 13(14): 1950 - 1960. [Abstract] [Full Text] |
||||
![]() |
N. Hagimoto, K. Kuwano, M. Kawasaki, M. Yoshimi, Y. Kaneko, R. Kunitake, T. Maeyama, T. Tanaka, and N. Hara Induction of Interleukin-8 Secretion and Apoptosis in Bronchiolar Epithelial Cells by Fas Ligation Am. J. Respir. Cell Mol. Biol., September 1, 1999; 21(3): 436 - 445. [Abstract] [Full Text] |
||||
![]() |
A. Costanzo, C. Guiet, and P. Vito c-E10 Is a Caspase-recruiting Domain-containing Protein That Interacts with Components of Death Receptors Signaling Pathway and Activates Nuclear Factor-kappa B J. Biol. Chem., July 16, 1999; 274(29): 20127 - 20132. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Linsinger, S. Wilhelm, H. Wagner, and G. Hacker Uncouplers of Oxidative Phosphorylation Can Enhance a Fas Death Signal Mol. Cell. Biol., May 1, 1999; 19(5): 3299 - 3311. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. F. Cheema, S. B. Wade, M. Sata, K. Walsh, F. Sohrabji, and R. C. Miranda Fas/Apo [Apoptosis]-1 and Associated Proteins in the Differentiating Cerebral Cortex: Induction of Caspase-Dependent Cell Death and Activation of NF-kappa B J. Neurosci., March 1, 1999; 19(5): 1754 - 1770. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Muhlenbeck, E. Haas, R. Schwenzer, G. Schubert, M. Grell, C. Smith, P. Scheurich, and H. Wajant TRAIL/Apo2L Activates c-Jun NH2-terminal Kinase (JNK) via Caspase-dependent and Caspase-independent Pathways J. Biol. Chem., December 4, 1998; 273(49): 33091 - 33098. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Miagkov, D. V. Kovalenko, C. E. Brown, J. R. Didsbury, J. P. Cogswell, S. A. Stimpson, A. S. Baldwin, and S. S. Makarov NF-kappa B activation provides the potential link between inflammation and hyperplasia in the arthritic joint PNAS, November 10, 1998; 95(23): 13859 - 13864. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Seino, K. Iwabuchi, N. Kayagaki, R. Miyata, I. Nagaoka, A. Matsuzawa, K. Fukao, H. Yagita, and K. Okumura Cutting Edge: Chemotactic Activity of Soluble Fas Ligand Against Phagocytes J. Immunol., November 1, 1998; 161(9): 4484 - 4488. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Jeremias, C. Kupatt, B. Baumann, I. Herr, T. Wirth, and K.M. Debatin Inhibition of Nuclear Factor kappa B Activation Attenuates Apoptosis Resistance in Lymphoid Cells Blood, June 15, 1998; 91(12): 4624 - 4631. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Kennedy and R. C. Budd Phosphorylation of FADD/MORT1 and Fas by Kinases That Associate with the Membrane-Proximal Cytoplasmic Domain of Fas J. Immunol., May 15, 1998; 160(10): 4881 - 4888. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Brenner, U. Koppenhoefer, C. Weinstock, O. Linderkamp, F. Lang, and E. Gulbins Fas- or Ceramide-induced Apoptosis Is Mediated by a Rac1-regulated Activation of Jun N-terminal Kinase/p38 Kinases and GADD153 J. Biol. Chem., August 29, 1997; 272(35): 22173 - 22181. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Biancone, A. D. Martino, V. Orlandi, P. G. Conaldi, A. Toniolo, and G. Camussi Development of Inflammatory Angiogenesis by Local Stimulation of Fas In Vivo J. Exp. Med., July 7, 1997; 186(1): 147 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Gamard, G. S. Dbaibo, B. Liu, L. M. Obeid, and Y. A. Hannun Selective Involvement of Ceramide in Cytokine-induced Apoptosis. CERAMIDE INHIBITS PHORBOL ESTER ACTIVATION OF NUCLEAR FACTOR kappa B J. Biol. Chem., June 27, 1997; 272(26): 16474 - 16481. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Wiesner, J. P. Kilkus, A. R. Gottschalk, J. Quintans, and G. Dawson Anti-immunoglobulin-induced Apoptosis in WEHI 231Cells Involves the Slow Formation of Ceramide from Sphingomyelin and Is Blocked by bcl-xL J. Biol. Chem., April 11, 1997; 272(15): 9868 - 9876. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mandal, S. B. Maggirwar, N. Sharma, S. H. Kaufmann, S.-C. Sun, and R. Kumar Bcl-2 Prevents CD95 (Fas/APO-1)-induced Degradation of Lamin B and Poly(ADP-ribose) Polymerase and Restores the NF-kappa B Signaling Pathway J. Biol. Chem., November 29, 1996; 271(48): 30354 - 30359. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Van Antwerp, S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma Suppression of TNF-alpha -Induced Apoptosis by NF-kappa B Science, November 1, 1996; 274(5288): 787 - 789. [Abstract] [Full Text] |
||||
![]() |
F. Mackay, G. R. Majeau, P. S. Hochman, and J. L. Browning Lymphotoxin beta Receptor Triggering Induces Activation of the Nuclear Factor kappa B Transcription Factor in Some Cell Types J. Biol. Chem., October 4, 1996; 271(40): 24934 - 24938. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wajant, E. Haas, R. Schwenzer, F. Muhlenbeck, S. Kreuz, G. Schubert, M. Grell, C. Smith, and P. Scheurich Inhibition of Death Receptor-mediated Gene Induction by a Cycloheximide-sensitive Factor Occurs at the Level of or Upstream of Fas-associated Death Domain Protein (FADD) J. Biol. Chem., August 4, 2000; 275(32): 24357 - 24366. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. F. Tran, T. H. Holmstrom, M. Ahonen, V.-M. Kahari, and J. E. Eriksson MAPK/ERK Overrides the Apoptotic Signaling from Fas, TNF, and TRAIL Receptors J. Biol. Chem., May 4, 2001; 276(19): 16484 - 16490. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Siegmund, D. Mauri, N. Peters, P. Juo, M. Thome, M. Reichwein, J. Blenis, P. Scheurich, J. Tschopp, and H. Wajant Fas-associated Death Domain Protein (FADD) and Caspase-8 Mediate Up-regulation of c-Fos by Fas Ligand and Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) via a FLICE Inhibitory Protein (FLIP)-regulated Pathway J. Biol. Chem., August 24, 2001; 276(35): 32585 - 32590. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Faouzi, B. E. Burckhardt, J. C. Hanson, C. B. Campe, L. W. Schrum, R. A. Rippe, and J. J. Maher Anti-Fas Induces Hepatic Chemokines and Promotes Inflammation by an NF-kappa B-independent, Caspase-3-dependent Pathway J. Biol. Chem., December 21, 2001; 276(52): 49077 - 49082. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals |